mRNA vaccinations have destroyed immune systems of millions

The chilling warning was issued by the associate professor of pharmacology and toxicology at the University of Western Australia, Dr. Phil Burcham.

In a blistering critique published in the May 2025 edition of the journal Quadrant, Burcham raises urgent questions about the chemical design and safety testing of Covid mRNA “vaccines.”

Drawing upon firsthand injury experience, insider pharmaceutical literature, and decades of toxicological science, Burcham alleges that the deployment of mRNA-LNP technologies ignored well-known formulation risks.

The Covid mRNA injections also exposed patients to unvalidated toxic excipients and sidestepped rigorous preclinical evaluation, he argues.

Burcham’s article, titled “An Injured Toxicologist Reflects on COVID mRNA Vaccines (Part II),” interrogates the molecular architecture of mRNA-lipid nanoparticle (LNP) platforms.

He contends that serious and rapid-onset toxicities experienced by thousands of Australians stem not solely from immune responses to spike protein but from the synthetic materials used to construct LNP delivery systems.

The top professor notes that his own debilitating trigeminal nerve injury was caused by a Covid mRNA “vaccine.”

These synthetic materials used to construct LNP delivery systems include:

• Ionizable lipids (e.g., SM-102, ALC-0315)
• PEGylated lipids
• Unnatural modified nucleotides (e.g., pseudouridine)

Burcham’s central thesis is that mRNA vaccines were built upon unstable, “pharmacologically obese” molecules with seven well-known liabilities.

He explains that chemists tried to patch these liabilities using risky excipients rather than structural redesign.

While not an empirical study in itself, the essay draws heavily on:

• Burcham’s personal toxicological training and vaccine injury
• Published toxicology and pharmacology literature (e.g., Liu, Vaccines, 2019)
• A 2021 exposé by Ryan Cross in Chemical & Engineering News
• Unpublished biodistribution concerns from Pfizer’s own regulatory filings

This makes the piece a hybrid: expert commentary, post-market pharmacovigilance hypothesis, and forensic review of neglected preclinical science.

In his searing analysis, Burcham exposes deep flaws in the pharmacological vetting of LNP components used in Covid mRNA “vaccines.”

Neither Pfizer’s nor Moderna’s mRNA lipids were supported by robust toxicological data before their mass public rollout.

Despite their pivotal role in delivering mRNA payloads, these ionizable lipids lacked transparent preclinical safety disclosures.

According to science journalist Ryan Cross’s 2021 reporting, insiders acknowledged that most LNP candidates failed in animal models after promising in vitro performance...

If Burcham’s account is correct, then millions of people, especially those reporting rapid-onset or persistent neurological symptoms, may have been injured not solely by the spike protein but by the very materials used to deliver it.

The implications for regulatory reform, vaccine injury compensation, and pharmaceutical transparency are profound.

However, this data has never reached the public domain. Read more.

A blog series on the Fastzone.substack.com site featured an excellent seminar on Covid19 held in Oldham Co. in 2022. The series offers substantial background on this topic.